FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹308 Cr | ₹257 Cr | ₹187 Cr | ₹162 Cr | ₹141 Cr |
What is the latest Total Liabilities ratio of FREDUN PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹308 Cr |
Mar2023 | ₹257 Cr |
Mar2022 | ₹187 Cr |
Mar2021 | ₹162 Cr |
Mar2020 | ₹141 Cr |
How is Total Liabilities of FREDUN PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹308 Cr | 19.56 | |
Mar2023 | ₹257 Cr | 37.59 | |
Mar2022 | ₹187 Cr | 15.70 | |
Mar2021 | ₹162 Cr | 14.32 | |
Mar2020 | ₹141 Cr | - |
Compare Total Liabilities of peers of FREDUN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FREDUN PHARMACEUTICALS | ₹453.6 Cr | 16% | 15.3% | 8.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
FREDUN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FREDUN PHARMACEUTICALS | 16% |
15.3% |
8.9% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses